Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Open accessThe DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Abstract
Pain is common in cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70% [1], contributing to poor physical and emotional well-being. The most comprehensive systematic review indicates pain prevalence ranging from 33% in patients after curative treatment, to 59% in patients on anticancer treatment and to 64% in patients with metastatic, advanced or terminal disease [2]. Pain has a high prevalence earlier in disease in specific cancer types such as pancreatic (44%) and head and neck cancer (40%) [3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 2 The assessment of BTcP. BTcP, breakthrough cancer pain. Reprinted with permission from [116].](https://figures.cochat.ai/paper-figures/ca72788a69f549f1926fbf99429f0118/management-of-cancer-pain-in-adult-patients-esmo-clinical-practice-guidelines-figure-2.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the recent ESMO guidelines106 are difficult to follow in those countries where the majority of patients experiencing cancer pain live.”
From 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pain and Its Treatment in Outpatients with Metastatic Cancer
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300902 · Cited by 2,019
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm056 · Cited by 1,923
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citation
Cited by
Items 501–600 of 954
Duque, M. O. G., Orrego-Villegas, E., Arenas, F., Fernández-Correa, T., & Probst-Girón, N. P. (2023) · CES Medicina · doi:10.21615/cesmedicina.7197 · Cited by 5
Yamamoto, Y., Yamamoto, S., Tsuge, T., Urano, K., & Matsuura, K. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2023.0314 · Cited by 2
“8 OINV may exhibit significant interindividual variation in the frequency, severity, or development of tolerance of nausea and/or vomiting among patients; thus, nausea and vomiting effects are more difficult to fully control in the majority of patients.”
Cancer survivors and cancer pain
Craig, T., Napolitano, A., & Brown, M. R. D. (2024) · BJA Education · doi:10.1016/j.bjae.2024.05.002 · Cited by 2
Alcañiz-Mesas, A. I., Ruiz-García, M.-V., Jiménez, M. P. C., Caballero-García, M.-J., & Álvarez, M. D. C. (2024) · Enfermería Clínica (English Edition) · doi:10.1016/j.enfcle.2024.11.002 · Cited by 2
Guan, J., Qi, F., Liang, H., Liu, X., Zhao, Z., Chen, L., Zhang, R., Yang, R. Y., Göker, B., Singh, S., et al. (2025) · Cancers · doi:10.3390/cancers17061015 · Cited by 2
“However, due to the persistent invasion of the tumor into bone tissue and subsequent compromised mechanical properties, pain control often remains palliative, and long-term use of analgesics is associated with significant side effects [6,7].”
Palliative radiotherapy for bone metastases: conventional external beam radiotherapy
Kibe, Y., & Nakamura, N. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02795-1 · Cited by 3
“Cancer-related neuropathic pain arises from direct damage to the somatosensory system, such as MSCC or nerve root compression caused by spinal metastases [17].”
Cancer pain: current practice and emerging targets
Ye, Y., Chwistek, M., Gong, Z., Uzonwanne, V. O., Shi, X., & SZALLASI, A. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70410 · Cited by 5
Antal, A., Ramasawmy, P., Rubal‐Otero, L., Chakalov, I., Rodríguez, M. Á., Hunold, A., Schellhorn, K., & Carrillo‐de‐la‐Peña, M. T. (2025) · BMC Cancer · doi:10.1186/s12885-025-15143-3 · Cited by 2
“To achieve a more sustainable and personalized cancer pain management, the European Society for Medical Oncology recommends a multimodal treatment approach comprising primary anti-tumor therapy, analgesic treatment, and non-pharmacological and non-invasive therapeutic approaches [10].”
Efficacy of neuromodulation techniques (TMS and tDCS) in cancer pain management: A systematic review
Fernandes, S. M. S. R., Peixoto, J., Rodrigues, P. F. S., & Bártolo, A. (2025) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2025.100651 · Cited by 2
“Chronic pain, defined as persistent or recurrent pain lasting more than three months (Bennett et al., 2019), affects 33 – 40 % of cancer survivors, with 5 – 10 % experiencing pain that significantly interferes with functionality (Fallon et al., 2018).”
Acupuncture as Adjunctive Therapy for Cervical Cancer Pain: A Systematic Review and Meta-Analysis
Shi, A., Yerebake, M., Du, Z., Li, L., Yan, C., & Wang, J. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.12.013 · Cited by 3
Slotman, E., Hedman, C., Fransen, H., van der Linden, Y. M., Raijmakers, N., & Lundstrom, S. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-026-10349-y · Cited by 6
“Although existing pain management guidelines emphasize the important role of routine pain assessment [9, 40], adherence to pain assessment is still suboptimal and mentioned as one of the main barriers to effective pain management [15–17, 41, 42].”
Paracetamol and NSAIDs in Cancer Pain Management: Evidence Review and Treatment Considerations
Hanwell, K., Bradley, A., & Boland, J. W. (2026) · Current Treatment Options in Oncology · doi:10.1007/s11864-025-01368-8 · Cited by 2
“The use of paracetamol and NSAIDs both alone and as adjuncts to opioids in cancer pain is recommended by international guidelines [5 – 7].”
Shen, S., Liu, D., Shen, X., He, S., Liu, X., Xu, H., Zhou, K., Zhang, Y., & Gou, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-43569-7 · Cited by 2
Opioid-induced neurotoxicity in palliative medicine: a rapid review
Bihan, A. L., Bridge, S., & Hedges, V. (2026) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2025-006002 · Cited by 2
Phenol Neurolysis in Pain and Palliative Medicine
Creemers, J. H. A., Smits, R. J. H., Patel, A. M., van Dongen, R. T. M., Kramers, C., Bos, J. M., & van der Wal, S. E. I. (2026) · Pain Practice · doi:10.1111/papr.70153 · Cited by 2
Thota, R. S., Chatterjee, A. S., Ramanjulu, R., Ahmed, A., Bhattacharya, D., Salins, N. S., Jain, P. N., & Bhatnagar, S. (2020) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.285691 · Cited by 3
“[10] Cancer pain management guidelines have been published by the clinical practice guidelines management of cancer pain (Malaysian Cancer Pain Guidelines, July 2010), Ministry of Health Clinical Practice Guidelines 5/2003 (Singapore), Scottish Intercollegiate Guidelines Network 2008, European Society of Medical Oncol…”
BackgroundAcupuncture for chronic cancer-related pain: a systematic review and network meta-analysis protocol
Yang, J., Xu, G., Yin, Z., Cheng, Y., Sun, S. M., Zheng, Q., Chen, J., Liang, F., & Zhao, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039087 · Cited by 2
“11 12 Each adverse effect requires a careful assessment and treatment strategy, and increase the financial burden of patients.”
BackgroundAttitudes and appropriateness of pain management in cancer patients using pain management index
Ayoub, N. M., Nuseir, K. Q., Al-Shamali, Y. A., & Al-Zoubi, A. (2020) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmaa005 · Cited by 2
BREAST CANCER IN PREGNANCY AT DR. KARIADI GENERAL HOSPITAL: A SERIAL CASE
Martono, I. V., Pramono, B. A., Kristanto, H., & Adrianto, A. A. (2021) · Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) · doi:10.14710/dmj.v10i2.29172 · Cited by 2
Ghanem, M. (2021) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-021-00169-z · Cited by 2
Wang, J., Lai, Z., Zhou, X., Song, N., Zhang, L., & Cheng, J. (2022) · Journal of Oncology · doi:10.1155/2022/1459636 · Cited by 2
“)ese therapeutic methods have the advantages of quick onset, safety, nontoxic side effects, and easy acceptance by patients [8, 9].”
BackgroundA form to report pain assessment and monitoring in the oncology clinical record: a Delphi process
Marinangeli, F., Tonini, G., Aglietta, M., Gentili, M., Cappellini, F., Giacomelli, L., & Biasco, G. (2023) · Future Oncology · doi:10.2217/fon-2022-1109 · Cited by 2
Takahashi, R., Miyashita, M., Oba, M. S., & Murakami, Y. (2023) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyad058 · Cited by 2
Cancer Patients with Chronic Pain and Their Caregivers during COVID-19: A Descriptive Study
Costeira, C. R. B., Paiva-Santos, F., Pais, N. J., Sousa, A. F., Paiva, I., Carvalho, D. H., Rocha, A. M. D. N., & Ventura, F. I. Q. S. (2023) · Nursing Reports · doi:10.3390/nursrep13030082 · Cited by 5
Cancer pain intensity and perceived social support in palliative care: 1-week prospective study
Yang, Y., Cui, M., Zhao, X., Wang, S., Wang, Y., & Wang, X. (2023) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2023-004236 · Cited by 2
Leppert, W., Wordliczek, J., Malec‐Milewska, M., Kocot-Kępska, M., Woroń, J., Zajączkowska, R., Dobrogowski, J., Krzakowski, M. J., & Krajnik, M. (2024) · Oncology in Clinical Practice · doi:10.5603/ocp.2023.0029 · Cited by 4
Zhang, J., Ma, K., Yan, J., Pan, P., Yin, J., Lin, F., Chen, H., Zhao, W., Chen, M., Zhang, Z., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s452605 · Cited by 2
Definition and Assessment of Paediatric Breakthrough Pain: A Qualitative Interview Study
Dawson, E., Greenfield, K., Carter, B., Bailey, S., Anderson, A.-K., Rajapakse, D., Renton, K., Mott, C. E., Hain, R. D., Harrop, E. J., et al. (2024) · Children · doi:10.3390/children11040485 · Cited by 2
“Experts recommend validated assessment questionnaires to diagnose and manage BTP [7,32,33].”
BackgroundKallman, T. F., & Bäckryd, E. (2024) · PAIN Reports · doi:10.1097/pr9.0000000000001183 · Cited by 4
Clark, M. D., Bramati, P. S., Singleton, G. A., Troyer, J., Alizadeh, P., Berly, A., Fellman, B. M., Hui, D., & Bruera, E. D. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.09.016 · Cited by 2
Voznyuk, S., Carter, R. Z., & Ridley, J. (2024) · Palliative Medicine · doi:10.1177/02692163241286658 · Cited by 3
“The ESMO guidelines on refractory symptom management and end-of-life care in cancer patients 48,51–53 demonstrate versatility and applicability of their system to various palliative care settings, serving as proof of concept and evidence of congruity.”
Kitamura, M., Morioka, Y., Kobayashi, M., & Ushida, T. (2024) · PAIN RESEARCH · doi:10.11154/pain.39.64 · Cited by 2
“Traditionally, opioids have been the drugs of first choice for managing moderate to severe cancer pain (1).”
Role of Herbal Essential Oil in Cervical Cancer: A Systematic Review
Sah, S., Kumar, R., Saini, R., & Patil, S. M. (2024) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.3.5.10 · Cited by 2
“A hybrid of molecules that had geraniol and butanolide moieties was created and synthesised by Takamura's research group [34].”
BackgroundMethodFontaine, C., Libert, I., Echterbille, M.-A., Bonhomme, V. L., Botterman, J., Bourgonjon, B., Brouillard, V., Courtin, Y., Buck, J. D., Debruyne, P. R., et al. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08984-4 · Cited by 2
“Overall, neuropathic pain was also treated according to guidelines in most centers with pregabalin, gabapentin, tricyclic antidepressants, and duloxetine/venlafaxine being used in over 90% of the surveyed centers [9].”
Hofbauer, H., Kieselbach, K., Wirz, S., Bundscherer, A., Stamer, U. M., & Rapp, F. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-09081-2 · Cited by 3
Pain catastrophizing is associated with high-dose opioids in patients with cancer pain
van Rysewyk, S., Lovell, M. R., & Glare, P. A. (2024) · Academia Medicine · doi:10.20935/acadmed7448 · Cited by 2
Cannabidiol from Conventional to Advanced Nanomedicines for the Management of Cancer-Associated Pain
Jain, A., Qureshi, S. A., Rafiya, K., Ali, I., Shahrukh, M., Hasan, N., & Ahmad, F. J. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273337554250311060327 · Cited by 3
Pituitary Targeting for Intractable Cancer Pain: A Systematic Review and Current Recommendations
Balossier, A., Soussi, G., & Régis, J. M. (2025) · Stereotactic and Functional Neurosurgery · doi:10.1159/000547889 · Cited by 2
“Clinical guidelines suggest that failure to achieve adequate analgesia or the presence of intolerable side effects should be an indication of referral to interventional therapies [45].”
The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Mangana, J., Özdemir, B. C., Mihic‐Probst, D., Siano, M., Metaxas, Y., Maul, L. V., Hunger, R. E., Lindenblatt, N., Olariu, R., von Moos, R., et al. (2025) · Swiss Medical Weekly · doi:10.57187/s.4210 · Cited by 2
Tzikos, G., Menni, A.-E., Theodorou, H., Chamalidou, E., Theodorou, I. M., Stavrou, G., Shrewsbury, A. D., Amaniti, A., Konsta, A., Tsetis, J. K., et al. (2025) · Nutrients · doi:10.3390/nu17172751 · Cited by 3
“Therefore, effective pain control is not only an ethical imperative and a medical obligation under the right to health [24] but also a clinical necessity to support optimal recovery and therapeutic efficacy [3].”
Jain, R. (2020) · Journal of Prescribing Practice · doi:10.12968/jprp.2020.2.3.147 · Cited by 2
Kannabisz használata az onkológiában: tények és tévhitek
Kürönya, Z., Martin, T., Edina, K., Szőnyi, M. D., & Bíró, K. (2020) · Orvosi Hetilap · doi:10.1556/650.2020.31733 · Cited by 2
Cannabis bei Krebs – für welchen Einsatz haben wir Evidenz?
Zomorodbakhsch, B., & Hübner, J. (2022) · Die Onkologie · doi:10.1007/s00761-022-01197-6 · Cited by 2
Hernández-Porras, B. C., Plancarte, R., Jiménez‐Andrade, J. M., & Koyyalagunta, D. (2021) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_4_21 · Cited by 2
Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J Study): A Post Hoc Analysis
Tokoro, A., Imai, H., Fumita, S., Harada, T., Noriyuki, T., Gamoh, M., Okamoto, M., Akashi, Y., & Kizawa, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184193 · Cited by 2
Rueter, M., Baricault, B., & Lapeyre‐Mestre, M. (2022) · Therapies · doi:10.1016/j.therap.2022.01.019 · Cited by 2
Wu, P., Zhu, L., Zheng, S., Li, J.-X., Wu, M., Wang, W.-J., Hou, Y., Li, J., & Wu, H. (2022) · Journal of Pain Research · doi:10.2147/jpr.s361821 · Cited by 2
“At present, the vast majority of cancer patients are not only tortured by cancer pain, but also by the side effects of opioids.(13) A systematic review showed that acupuncture could significantly reduce cancer pain and analgesic administration.”
BackgroundComprehensive Targeted Treatment for Neuropathic and Nociceptive Pain in Palliative Care Patients
Mihăilescu-Marin, M.-M., Mosoiu, D. V., & Dima, L. (2022) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001536 · Cited by 5
Mercadante, S. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2200137 · Cited by 1
“Although data regarding their efficacy in neuropathic cancer pain are scarce, they remain the main drugs used in patients with cancer pain with a neuropathic component [6,84].”
BackgroundWood, T., Cheung, W. Y., Ruether, D., Sinnarajah, A., Tanguay, R. L., Tarumi, Y., Lau, J., & Cuthbert, C. A. (2023) · JCO Oncology Practice · doi:10.1200/op.22.00766 · Cited by 2
Increasing Provider Self-Efficacy to Manage Chronic Cancer Pain
Jackson, C., & Jackson, C. (2023) · Pain Management Nursing · doi:10.1016/j.pmn.2023.08.002 · Cited by 2
Ordoñez‐Mora, L. T., Rosero, I. D., Osorio, M. A. M., Bozal, R. G., Jordan, G. Q., Agudelo, J. A., González‐Ruíz, K., & Valencia, J. C. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071493 · Cited by 4
Shkodra, M., Mulvey, M. R., Fallon, M., Brunelli, C., Zecca, E., Bracchi, P., Caputo, M., Massa, G., Dico, S. L., Rolke, R., et al. (2024) · PAIN Reports · doi:10.1097/pr9.0000000000001140 · Cited by 4
“3 Because cancer pain treatment guidelines 8,13 recommend specific adjuvant treatments for NcP, the lack of a standardized assessment method for its diagnosis is certainly clinically relevant.”
BackgroundSelf-citationInterventions for cancer-related pain
Xu, T., Lei, H., Zhang, Y., Huang, S., Wang, Z., Zhou, S., Yang, J., Zheng, Q., Chen, J., & Zhao, L. (2019) · Medicine · doi:10.1097/md.0000000000017844 · Cited by 2
Pharmacological Treatment of Established Chemotherapy-Induced Peripheral Neuropathy
Mayo, S. J., Toh, Y. L., Oh, J. H., & Chan, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-78663-2_7 · Cited by 3
The end of the second step of the World Health Organization analgesic ladder?
Bramati, P. S., & Bruera, E. D. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.08.085 · Cited by 2
La gestion de la douleur chez les patients atteints du cancer dans un hôpital tunisien
Tlijani, M., Sayadi, M., Zribi, K., Jbeli, F., Zaied, S., Daldoul, A., Salah, Y. B., Saïdani, Z., & Cherif, A. (2021) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.12.013 · Cited by 1
de Albuquerque, L. Z., da Silva, J. L., dos Santos, A. L. S., Rodrigues, I. P., & de Melo, A. C. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01183-2 · Cited by 1
Schmerztherapie mit adjuvanten Analgetika
Sator, S. (2022) · Schmerz Nachrichten · doi:10.1007/s44180-022-00027-w · Cited by 1
Chronic pain in cancer patients
Moisieienko, A., Marchuk, O., Lisnyy, I. I., & Dmytrіiev, D. (2022) · Pain medicine · doi:10.31636/pmjua.v7i2.1 · Cited by 1
Predictors for the Clinical Efficacy of Tramadol for Cancer Pain
Koutake, Y., Fujimoto, A., Nakahara, M., Tsuruyama, M., Miyoshi, T., Yamaguchi, Y., Fukazawa, M., Kawamata, Y., Hanada, K., & Hashimoto, M. (2023) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091231152854 · Cited by 1
Ruggiero, E., Pambuku, A., Caccese, M., Lombardi, G., Gallio, I., Brunello, A., Ceccato, F., & Formaglio, F. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1256809 · Cited by 3
“After adequate titration, extended-release or long-acting opioid formulation should be provided with around-the-clock dosing in all patients, with the supply of a rescue short-acting medication to manage breakthrough or transient pain exacerbations (12, 26, 27).”
BackgroundMechanism and application of acupuncture and electro‐acupuncture associated with cancer therapy
Yang, X., Li, G., Yang, J., & Ma, X. (2024) · MedComm – Oncology · doi:10.1002/mog2.73 · Cited by 5
Effect of auricular point acupressure combined with three-step analgesic therapy on cancer pain
Huang, X., Cai, H., Zeng, W., Zeng, X., Xiao, X., Liu, Y., Xu, Y., Liu, X., & Zhong, Q. (2025) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh240919022h · Cited by 1
Cognitive Impairment in Caregivers of Cancer Patients: A Cross-sectional Study
Taşçı, E. Ş., Yazar, A., Orhun, Ö., Kara, M., Oyan, B., Başaran, G., Sönmez, Ö., Seçim, E., & Yüce, S. (2024) · Acta haematologica oncologica Turcica. · doi:10.4274/ahot.galenos.2024.89896 · Cited by 1
Validation of the Spanish Version of the Breakthrough Pain Assessment Tool in Patients With Cancer
Gonzalez, R., Guillen, R., Rocha‐Romero, A., Carvajal-Valdy, G., Avendaño-Pérez, L., & Webber, K. (2024) · Cureus · doi:10.7759/cureus.69135 · Cited by 1
“Cancer pain is an unrelenting symptom that negatively alters the quality of life, and the quality of life itself can alter sleep patterns and reduce physical activity and mental health [4-6].”
BackgroundQuan, L., & Fan, J. (2024) · International Journal of Radiation Research · doi:10.61186/ijrr.22.2.505 · Cited by 1
Alcañiz-Mesas, A. I., Ruiz-García, M.-V., Jiménez, M. P. C., Caballero-García, M.-J., & Álvarez, M. D. C. (2024) · Enfermería Clínica · doi:10.1016/j.enfcli.2024.07.001 · Cited by 1
Sublingual and buccal drug administration in medical emergencies
Roma, J. R., Rebollo, P. C., & Bastida, C. (2024) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.05.028 · Cited by 3
Liu, J., Somjaivong, B., Panpanit, L., & Zhang, L. (2024) · Pain Management Nursing · doi:10.1016/j.pmn.2024.10.009 · Cited by 1
Therapie tumorassoziierter Schmerzen – von medikamentös bis invasiv
Hofbauer, H., Wirz, S., Steffen, P. R. P., Kieselbach, K., & Keßler, J. (2024) · Die Anaesthesiologie · doi:10.1007/s00101-024-01488-0 · Cited by 1
The use of precision radiotherapy for the management of cancer-related pain in the abdomen
Glynn, A., Lawrence, Y. R., Dawson, L. A., & Barry, A. S. (2024) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000738 · Cited by 1
Automatic Pain Detection Algorithm for Patients with Cancer Pain Using Wristwatch Wearable Devices
Hirayama, H., Yoshida, S., Sasaki, K., Yuda, E., Masukawa, K., Sato, M., Ikari, T., Inoue, A., Kawasaki, Y., & Miyashita, M. (2024) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc53108.2024.10781536 · Cited by 1
Duarte, S., Rocha-Neves, J. P., Dourado, M., & Ribeiro, H. C. (2025) · Applied Biosciences · doi:10.3390/applbiosci4010003 · Cited by 2
Bakker, W. A., Bertayli, M., Dumas, D. B., Elassaiss‐Schaap, J., Juachon, M. J., Broekhuizen, K., Hijma, H. J., & Groeneveld, G. J. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00696 · Cited by 1
The Role of Rehabilitation for Women with Cancer
Raj, V. S., Patel, B. D., Mullan, S., Hine, R., Mack, P. P., & Pugh, T. M. (2025) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2024.11.007 · Cited by 1
Semenkov, A. V., Bogdanov-Berezovsky, A. A., Skugarev, A. L., & Tulskih, D. A. (2025) · P A Herzen Journal of Oncology · doi:10.17116/onkolog20251402152 · Cited by 1
Tagami, K., Kessoku, T., Hasuo, H., Ishiki, H., Yamaguchi, T., Mori, M., Hiratsuka, Y., Kosugi, K., Okuda, Y., Yamaguchi, T., et al. (2025) · Cancers · doi:10.3390/cancers17101630 · Cited by 1
Suzuki, K., Matsuda, Y., Mori, M., Tasaki, J., Matsunuma, R., Ikari, T., Miwa, S., Aiki, S., Takagi, Y., Kiuchi, D., et al. (2025) · Journal of Palliative Medicine · doi:10.1089/jpm.2024.0487 · Cited by 1
Ippolito, E., Toppi, L., Carrafiello, S., Greco, C., Fiore, M., Alaimo, R., Minuti, S., Pantano, F., Casale, G., D’Angelillo, R. M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134662 · Cited by 1
Puuniemi, L., Iivanainen, S., Arffman, M., Kaarteenaho, R. L., & Koivunen, J. P. (2025) · Cancer Medicine · doi:10.1002/cam4.71040 · Cited by 1
Buprenorphine-Naloxone for Chronic Cancer-Related Pain in a Palliative Care Clinic
Tarumi, Y., Baracos, V. E., Lowe, S. S., Ademola, A., Chabassol, A., Wildeman, T., Sellick, M., Dutka, J., Ha, V., & Watanabe, S. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.07.006 · Cited by 3
Bibliometric and visual analysis of digital healthcare in cancer pain management via mobile apps
Shen, Q.-S., Kan, H., Wang, R., Li, N., Wang, S., & Rong, X. (2025) · Medicine · doi:10.1097/md.0000000000043603 · Cited by 2
“[5] The most commonly used medications are currently opioid analgesics.”
Budiastuti, R. F., Sari, S. P., Andrajati, R., & Syafhan, N. F. (2025) · HOLISTIK JURNAL KESEHATAN · doi:10.33024/hjk.v19i5.872 · Cited by 1
Validation of nine prognostic models in patients with bone metastases undergoing surgery
Smolle, M. A., Elmer, P., Wenzl, F. A., Leitner, L., Ferlic, P. W., Scheipl, S., Sadoghi, P., & Leithner, A. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-06147-7 · Cited by 1
“…fractures (that are indicative of a fast progressing underlying malignancy and thus of worse prognosis [35, 36]), with patients who present with small, stable, or slowly progressing bony lesions (that can be managed by means of analgesics, bisphosphonates, den-osumab or RTX[5]) was avoided, though.”
InfluentialThe MyPath Pain Pathway: Developing a Digital Patient-Centred Care Pathway for Cancer Pain
Shkodra, M., Urrizola, A., Fallon, M., Sjøgren, P., Everdingen, M. H. J. V. D. B.-V., Hagen, K. M. R., Decoster, L., Mosoiu, D. V., Hjermstad, M. J., Lundeby, T., et al. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.08.012 · Cited by 2
Self-citationRakıcı, S. Y., Yılmaz, A., & Karakas, S. M. (2025) · Life · doi:10.3390/life15091372 · Cited by 2
“The prevalence of pain in cancer patients is between 33% and 64%, depending on the stage of the disease [3].”
Gaertner, J., Appenzeller‐Herzog, C., Piechotta, V., Schwarzer, G., Rémi, C., Suter, K., & Boehlke, C. S. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016207 · Cited by 1
Pain and Its Treatment Among Outpatients with Malignant Tumors in China
Mao, P., Tian, X., Zhan, Y., Gao, F., Tan, X., Yu, H., Du, X., Li, J., Feng, G., Zhang, J., et al. (2025) · Cancer Management and Research · doi:10.2147/cmar.s532474 · Cited by 1
Donati, C. M., Galietta, E., Cellini, F., Zamfir, A. A., Rito, A. D., Portaluri, M. G. A., Santacaterina, A., Mammini, F., Franco, R. D., Parisi, S., et al. (2025) · Cancers · doi:10.3390/cancers17183073 · Cited by 1
Sami, S. H. A. (2025) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552251381791 · Cited by 1
Cannabis Laws and Opioid Use Among Commercially Insured Patients With Cancer Diagnoses
Lozano‐Rojas, F., Bethel, V., Gupta, S., Steuart, S. R., Bradford, W. D., & Abraham, A. J. (2025) · JAMA Health Forum · doi:10.1001/jamahealthforum.2025.3512 · Cited by 1
Cheng, Y.-N., Zhang, M., Xie, C.-Q., Li, Z., Ge, Y.-F., Jin, Z.-H., Luo, Z., Zheng, C.-Y., Liang, C., Fang, D., et al. (2025) · Molecular Pain · doi:10.1177/17448069251395641 · Cited by 1
Update of the Australian Guideline for the Management of Cancer Pain in Adults
Lovell, M. R., Rizvi, F., Luckett, T., Agar, M. R., Phillips, J. L., Boyle, F. M., Stubbs, J. H., Hucker, T. R., Gawarikar, R., Shaheed, C. A., et al. (2025) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.70047 · Cited by 1
Advances in research on cancer pain management for elderly patients in China
Wang, S., Tian, C., Li, Y., Yang, M. H., Zhang, J., Zhuang, Y., He, T., Zhang, J., Xie, S., Wang, Y., et al. (2025) · Holistic Integrative Oncology · doi:10.1007/s44178-025-00207-y · Cited by 1
“Radiation relieves localized bone pain in 50%–80% of patients, with 30% achieving complete resolution [67, 68].”
Sripaew, S., Philip, J., Collins, A., Limsomwong, P., Weil, J., Kittichest, R., Vichitkunakorn, P., & Assanangkornchai, S. (2025) · BMC Palliative Care · doi:10.1186/s12904-025-01951-8 · Cited by 1
“This approach supplements ACP training in oncology and palliative care curricula [39] and helps address restricted oncology staff time for ACP during oncology visits.”
Pain management in hospice and palliative care: A primer for pharmacists
Irwin, M. N., Hallstrom, L., Polat, M. F., Fagan, T. J., & Quirk, K. C. (2025) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaf326 · Cited by 1
Pericapsular Nerve Group Phenol Neurolysis for Refractory Metastatic Hip Pain: A Case Series
Perez-Moreno, D., Forero, M., Juárez-Lemus, Á. M., & Mora-Arteaga, J. A. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.12.012 · Cited by 1
Martinsson, L., Brännström, M., Fransson, P., & Andersson, S. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-102830 · Cited by 1
Sugiyama, Y., Tasaki, Y., Mimura, Y., Naiki, T., Odagiri, K., Kataoka, T., Etani, T., Iida, M., Hasegawa, T., Furukawa, Y., et al. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf210 · Cited by 2
Metadata
- Authors
- Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I.
- Affiliations
- Edinburgh Cancer Research (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- University of L'Aquila (IT)
- Mount Vernon Cancer Centre (GB)
- RWTH Aachen University (DE)
- Walton Centre (GB)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv166-iv191
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2834719472
- Cited by
- 954
- References
- 184
- Citations by year
- 2026: 136 · 2025: 140 · 2024: 143 · 2023: 123 · 2022: 129 · 2021: 126 · 2020: 88 · 2019: 61 · 2018: 6
- FWCI
- 103.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Marie Curie (MCCC-RP-12-A14197, MCCC-RP-15-A18862, MCCC-RP-15-A19005)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric Pain Management Techniques
- Keywords
- cancer pain, pain management, advanced cancer, metastatic cancer, terminal cancer, pain prevalence, palliative care, analgesia
- MeSH terms
- Cancer Pain, Cancer Survivors, Pain, Procedural, Procedural Pain, Adult, Analgesics, Opioid, Antineoplastic Combined Chemotherapy Protocols, Europe, Humans, Medical Oncology, Neoplasm Staging, Neoplasms, Pain Measurement, Societies, Medical, Terminal Care, Prevalence, Treatment Outcome, Breakthrough Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.